The FDA has given the green light to Eli Lilly's Onswik, a once-weekly basal insulin injection designed for adults managing type 2 diabetes. This approval marks a significant step forward, providing an alternative to the traditional daily long-acting insulin shots, potentially improving treatment adherence and patient convenience.
Radiology is witnessing a transformative shift as practices increasingly integrate AI by developing and deploying it internally. These 'AI-native' radiology services are reshaping the landscape, blending technology creation directly with clinical application and establishing a new standard in medical imaging.
A newly approved AI tool named STAT+ is designed to analyze EKGs for severe heart attacks and also identify rarer signs of blocked arteries that are harder to detect. The company behind STAT+ highlights its capability to improve early diagnosis and patient outcomes by catching these less obvious patterns in heart activity.
A commission in the U.K. has put forward a set of recommendations aimed at regulating the use of artificial intelligence in healthcare. These guidelines are designed to ensure safe and effective integration of AI technologies in medical practice across the country.
CEOs of leading AI companies have predicted that artificial intelligence will revolutionize medicine by potentially eliminating most cancers and enhancing treatments for various diseases. However, the practical application of AI in the chaotic environment of emergency rooms reveals significant challenges, highlighting a gap between expectations and reality in healthcare technology.
John Whyte, CEO of the American Medical Association, emphasizes that AI should enhance healthcare by working alongside medical professionals rather than trying to replicate the existing system with fewer people.
Ezekiel J. Emanuel and Abe Baker-Butler predict that by 2030, autonomous AI will outperform both doctors working alone and those supported by AI in five fundamental cognitive medical tasks.
The FDA's approval of Rasonque, a novel drug for pancreatic cancer, was a major milestone for researchers aiming to improve treatment outcomes. However, despite this regulatory success, many patients are experiencing difficulties in obtaining timely access to the medication, raising concerns about distribution and availability.
In this episode of STAT Health Tech, we explore how Stryker is integrating Apple's Vision Pro virtual reality headset into surgical procedures, creating an innovative 'surgical cockpit.' We also cover the use of chatbots to combat loneliness and other developments in health technology.
Several major health organizations are implementing AI-driven chatbots to access and summarize patient records efficiently. These tools help clinicians save valuable time and improve the accuracy of diagnoses.